SquamousCellCarcinomaofSkin near Hudson, FL

Care Philosophy: Dr Bejanyan is an Associate Member, Program Leader of Blood and Marrow Transplant (BMT) and Head of the Leukemia/Myeloid Section of the BMT and Cellular Immunotherapy Department at Moffitt Cancer Center. She is an Associate Professor in Oncologic Sciences at the University of South Florida.Dr Bejanyan also served as the Clinical Scientific Co-Director of Moffitt Pharmacokinetics and Pharmacodynamics Core. As a physician investigator with clinical and research expertise in BMT and cellular immunotherapies for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), Dr Bejanyan focuses in advancing clinical and translational research by fostering innovative immune cell therapy strategies to treat leukemia.

Care Philosophy: Dr Lazarides received his MD degree from Duke University Medical School. He completed an Orthopaedic Surgery Residency at Duke University Medical Center, Department of Orthopaedic Surgery. Dr Lazarides most recently completed an Orthopaedic Oncology Fellowship at Mount Sinai Hospital-University of Toronto, Division of Orthopaedic Surgery, in Toronto, Canada. Dr Lazarides specializes in treating pediatric and adult patients with benign or malignant bone or soft tissue tumors of the musculoskeletal system. His focus is the treatment of sarcomas as well as benign tumors and metastatic bone disease.

Care Philosophy: Dr David Sallman is an Assistant Member in the Department of Malignant Hematology at Moffitt Cancer Center. Dr Sallman's clinical interests are myelodysplastic syndromes (MDS), acute myeloid leukemia (AML) and myeloproliferative neoplasms (MPN). Dr Sallman earned his MD degree from the University of South Florida College of Medicine. He completed an Internal Medicine Residency at Massachusetts General Hospital and, most recently, a Hematology/Oncology Fellowship at Moffitt Cancer Center.

Care Philosophy: Dr Isenalumehe earned her MD from Sophie Davis School of Biomedical Education, CUNY Medical College, City College of New York (BA/MD Program) / Albany Medical College, New York and her MS degree in Clinical and Biomedical Investigation from the University of Southern California, Los Angeles. She completed a combined Internal Medicine and Pediatric Residency at NJMS-Rutgers (former: University of Medicine and Dentistry of New Jersey, Newark, where she also served as Internal Medicine-Pediatrics Chief Resident. She completed a Pediatric Hematology-Oncology Fellowship at Children's Hospital of Los Angeles, University of Southern California, where she also served as Chief Fellow.

Care Philosophy: Dr Andreas Saltos is a Medical Oncologist and the Clinical Research Medical Director in the Department of Thoracic Oncology at Moffitt Cancer Center. Dr Saltos earned his MD from the University of Maryland School of Medicine in Baltimore. He completed his Internal Medicine Residency at the University of Maryland Medical Center in Baltimore before moving to Tampa, where he completed a Hematology and Medical Oncology Fellowship at the University of South Florida Morsani College of Medicine and Moffitt Cancer Center. Dr Saltos specializes in the treatment of thoracic malignancies, including all forms and stages of lung cancer.

Care Philosophy: Dr Costa is a Medical Oncologist at the Department of Breast Oncology at Moffitt Cancer Center in the Clinical Investigator Track since 2017. In 2011, Dr Costa completed a Master Degree in Clinical Research at University of Pittsburgh and Clinical Fellowship Training at Allegheny General Hospital, Pittsburgh, Pennsylvania. Dr Costa was an Instructor at the Developmental Therapeutics Program at Northwestern University, Chicago, where he developed early phase clinical trials for the treatment of breast cancer. He has already authored and co-authored over 40 scientific manuscripts.

Care Philosophy: Dr Extermann is Program Leader in the Senior Adult Oncology Program at Moffitt Cancer Center. Dr Martine Extermann is also a Professor of Oncology and Medicine at the University of South Florida. She earned her medical degree and a PhD at the University of Geneva, Switzerland. She has a Swiss Board Certification in Internal Medicine, specializing in Hematology-Oncology. She also holds ABIM certifications in Internal Medicine and Medical Oncology. She has worked at Moffitt since 1994 and has been a faculty member since 1997. Her clinical activity and research focus on cancer in older patients.

Care Philosophy: Dr Jennifer Eatrides is a member of the Moffitt Medical Group in the Satellite and Community Oncology Department practicing at Tampa General Hospital and Moffitt international Plaza. Dr Eatrides earned her MD degree with a research focus at the University of South Florida Morsani College of Medicine. She completed an Internal Medicine Residency and completed a Hematology and Oncology Fellowship at the University of South Florida and Moffitt Cancer Center. Dr Eatrides has a particular interest in hematologic malignancies. The MMG faculty at TGH provides invaluable medical oncology services to the large patient population of this leading regional hospital.

Care Philosophy: Dr Sharjeel Hooda is a Clinical Instructor-Member in the Moffitt Cancer Center Department of Satellite and Community Oncology. Dr Hooda is based at Moffitt International Plaza (MIP). Dr Hooda earned his MD and MS in Clinical Research at Emory University, Atlanta, Georgia. He completed an Internal Medicine Residency at Cleveland Clinic in Ohio where he also served as Chief Resident in Quality and Patient Safety. Dr Hooda completed a Hematology and Oncology Fellowship at the University of South Florida and Moffitt Cancer Center he also served as Chief Quality Fellow in Medicine.

Care Philosophy: Dr Jaglal completed his hematology/oncology fellowship at the University of South Florida and Moffitt Cancer Center. His research interests are in benign hematologic disorders: hemophilia, von Willebrand's disease, anemias, hemostasis and thrombosis disorders. Clinically, Dr Jaglal is a hematologist/oncologist and member of Moffitt Medical Group in the Satellite and Community Oncology Department practicing at Tampa General Hospital and Moffitt international Plaza. The MMG faculty at TGH provides invaluable oncology services to the large patient population of this leading regional hospital.

Biography: Dr. Ivan Borrello, MD is a Hematology Specialist who practices in Tampa, FL. He is 62 years old. Dr. Ivan Borrello, MD is affiliated with Tampa General Hospital and Tampa General Hospital.

Care Philosophy: Dr James Liu is a neurosurgeon who specializes in the surgical and radiosurgical treatment of brain and spine tumors. Currently, he is an Assistant Member in the Department of Neuro-Oncology at Moffitt Cancer Center and an Assistant Professor of Oncologic Sciences at the University of South Florida. He received his undergraduate education from the University of Michigan. He received a medical degree from Case Western Reserve University School of Medicine. He obtained his residency training in neurosurgery at the Cleveland Clinic. He also completed a post-doctoral fellowship in Cancer Stem Cell Biology at the Cleveland Clinic, during which he was awarded the Congress of Neurological Surgeons Tumor Fellowship.

Care Philosophy: Dr Ochoa-Bayona's interests are in traditional bone marrow transplant using high dose chemotherapy and autologous or allogeneic stem transplant to treat myeloma, lymphoma, advanced or recurrent germ cell tumors of the ovary and testis despite standard chemotherapy, myelodysplastic syndromes, acute and chronic leukemias. He completed his training in Internal Medicine, Hematology/Medical Oncology and Hematopoietic Stem Cell Transplantation from the University of Texas Health Science Center at San Antonio in 2002.

Care Philosophy: Dr Khimani's Clinical interest is specifically in Blood and Marrow transplantation. His area of focus is Lymphoma and Acute Leukemia. He routinely takes care of patients with Hodgkin's lymphoma, Non-Hodgkin's lymphoma, Acute Myeloid leukemia, acute lymphoblastic leukemia and myelodysplastic syndrome etc. who require autologous or allogeneic hematopoietic stem cell transplantation as a curative treatment option for their malignancy.